Showing results (531-540 of 555) with videos related to

Sort By:
Pageof 56
ESMO Open|June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II studyA Le Cesne, C Chevreau, C Perrin, et al.
Vaccine|November 9, 2004
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasiaIan H Frazer, Michael Quinn, Jim L Nicklin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2025
Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trialN Penel, A Italiano, J Wallet, et al.
JAMA|December 17, 2025
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical TrialD P Devanand, Thomas Wisniewski, Qolamreza Razlighi, et al.
Blood|May 16, 1998
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)F Witz, A Sadoun, M C Perrin, et al.
Gynecologic Oncology|March 25, 2021
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trialMonika Janda, Kristy P Robledo, Val Gebski, et al.
Breast (Edinburgh, Scotland)|November 2, 2019
CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC databaseP Gougis, M Carton, C Tchokothe, et al.
ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.
Molecular Pharmaceutics|August 27, 2021
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian CancerYaowu He, Tashbib Khan, Thomas Kryza, et al.
Theranostics|February 28, 2020
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S Harrington, Yaowu He, Tashbib Khan, et al.
Pageof 56